News

Pharmabiz42m
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer: Shanghai Wednesday, July 23, 2025, 14:30 Hrs ...
Pharmabiz1h
Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus surgery
Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus surgery: South San Francisco Wednesday, July 23, 2025, ...
Pharmabiz1h
Centre screens six crore individuals for sickle cell disease
The Central government has said that it has conducted screening of a total of six crore individuals for sickle cell disease (SCD) against the targeted seven crore under the National Sickle Cell ...
Pharmabiz2h
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line: Wuxi, China Wednesday, July 23, 2025, 13:00 Hrs [IST] WuXi Biolog ...
Pharmabiz2h
Centre approved 48 projects under PLI Scheme for bulk drugs, says Minister
Centre approved 48 projects under PLI Scheme for bulk drugs, says Minister: Our Bureau, New Delhi Wednesday, July 23, 2025, 12:45 Hrs [IST] The Central government has said that it ...
Pharmabiz2h
Centre expects to exceed target sales under PLI scheme for pharma in fourth year
Centre expects to exceed target sales under PLI scheme for pharma in fourth year: Our Bureau, New Delhi Wednesday, July 23, 2025, 12:20 Hrs [IST] The Central government is expecti ...
Pharmabiz3h
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US: Cambridge, Massachusetts Wednesday, July 23, 2025, 12:00 Hrs [IST] ...
Pharmabiz4h
Weisheng & Nandani Medical Laboratories collaborate to advance intelligent pharma quality in India
Weisheng & Nandani Medical Laboratories collaborate to advance intelligent pharma quality in India: Our Bureau, Mumbai ...
Pharmabiz6h
AstraZeneca to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca to invest $50 billion in America for medicines manufacturing and R&D: Cambridge, UK Wednesday, July 23, 2025, 09:00 Hrs [IST] AstraZeneca announces $50 billion of inve ...
Pharmabiz7h
MDC rejects Sun Pharma's application seeking separate ceiling price for antibiotic oral suspension
MDC rejects Sun Pharma's application seeking separate ceiling price for antibiotic oral suspension: Gireesh Babu, New Delhi Wednesday, July 23, 2025, 08:00 Hrs [IST] The Multidisc ...
Pharmabiz7h
DBT to create image biobanks with AI backing to improve diagnostic technologies
DBT to create image biobanks with AI backing to improve diagnostic technologies: Gireesh Babu, New Delhi Wednesday, July 23, 2025, 08:00 Hrs [IST] The Department of Biotechnology ...
Pharmabiz7h
GROWING ACCEPTANCE OF IP
This MoU will establish a framework for the recognition of the IP as a pharmacopoeia standard for assessing applications for market authorisation for medicinal products manufactured in India. Thus, it ...